Listen to this page using ReadSpeaker
Posts tagged avastin

ARVO 2015 Highlight: AMD Gene Therapy Performs Encouragingly in Human Study

an AMD eyeWhile treatments such as Lucentis®, Avastin®, and Eylea® have been saving and restoring vision for people with wet age-related macular degeneration (AMD) over the last several years, they have a significant drawback: The therapies require regular injections into the eye—in some cases, monthly—for the life of the patient.
Continue Reading…

Please follow and like us:
0

CME – What It Is, and Why People with Retinal Diseases Should Know About It

Dr. FishmanIn this Q&A, Gerald Fishman, M.D., a world-renowned clinical researcher and longstanding member of FFB’s Scientific Advisory Board, discusses cystoid macular edema (CME), a potentially damaging accumulation of fluid in the retina affecting up to 32 percent of people with retinitis pigmentosa (RP) and related conditions. It’s a complication that can make matters worse for retinas already fragile from degenerative disease. While diagnosis isn’t always straightforward, CME can be treated to minimize vision loss.
Continue Reading…

Please follow and like us:
0

Tempering the Immune System to Save Vision

A retina with dry AMD. The yellow spots (called drusen) accumulate and can cause damage in AMD. The human body has highly impressive mechanisms to protect itself from harm. For example, a group of molecules known as the complement system work with antibodies to kill invading bacteria by punching holes in them and letting the internal contents leak out.
Continue Reading…

Please follow and like us:
0

One and Done: The Next Revolution in Treating Wet AMD

Doctor and PatientToday, most people who develop wet age-related macular degeneration (AMD) can retain much of their vision thanks to the advent of three treatment options, all administered through repeated ocular injections.

Continue Reading…

Please follow and like us:
0